| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
37,001 |
27,061 |
$1.16M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
11,053 |
9,660 |
$575K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
3,182 |
2,536 |
$419K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
22,339 |
19,195 |
$340K |
| 88307 |
|
5,629 |
4,887 |
$287K |
| 80053 |
Comprehensive metabolic panel |
65,022 |
47,424 |
$65K |
| 88304 |
|
5,678 |
4,897 |
$52K |
| 88312 |
|
2,920 |
2,508 |
$49K |
| 88342 |
|
2,106 |
1,555 |
$47K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
598 |
586 |
$32K |
| 87631 |
|
426 |
410 |
$26K |
| 88112 |
|
1,574 |
1,223 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
76,745 |
53,371 |
$21K |
| 88141 |
|
1,364 |
1,161 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
28,074 |
13,817 |
$17K |
| 84443 |
Thyroid stimulating hormone (TSH) |
18,737 |
16,791 |
$17K |
| 88300 |
|
2,037 |
1,668 |
$15K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
395 |
333 |
$14K |
| 88142 |
|
916 |
804 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,513 |
5,193 |
$10K |
| 84165 |
|
2,418 |
2,086 |
$9K |
| 84484 |
|
14,169 |
10,558 |
$9K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
388 |
359 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,622 |
2,453 |
$8K |
| 81001 |
|
24,792 |
20,955 |
$7K |
| 88341 |
|
228 |
157 |
$6K |
| 85060 |
|
1,067 |
891 |
$6K |
| 83735 |
|
20,790 |
10,721 |
$6K |
| 86334 |
|
1,230 |
1,034 |
$5K |
| 82803 |
|
5,853 |
2,707 |
$5K |
| 80061 |
Lipid panel |
8,139 |
7,626 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,005 |
9,389 |
$4K |
| 87040 |
|
6,812 |
5,415 |
$4K |
| 85027 |
|
19,479 |
10,867 |
$4K |
| 83605 |
|
7,740 |
6,170 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,338 |
2,224 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,334 |
2,220 |
$4K |
| 83690 |
|
12,544 |
10,687 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,293 |
2,030 |
$3K |
| 80074 |
|
653 |
628 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,069 |
1,030 |
$3K |
| 84439 |
|
6,032 |
5,526 |
$3K |
| 82607 |
|
4,486 |
4,190 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,568 |
4,324 |
$2K |
| 80320 |
|
3,952 |
3,343 |
$2K |
| 84100 |
|
10,346 |
4,309 |
$2K |
| 87077 |
|
5,924 |
5,178 |
$2K |
| 86803 |
|
1,135 |
1,083 |
$2K |
| 83880 |
|
4,345 |
3,594 |
$2K |
| 82728 |
|
2,714 |
2,508 |
$2K |
| 87186 |
|
4,278 |
3,803 |
$2K |
| 81329 |
|
653 |
561 |
$1K |
| 84703 |
|
4,900 |
4,464 |
$1K |
| 88302 |
|
213 |
177 |
$1K |
| 86901 |
|
7,705 |
6,243 |
$1K |
| 87081 |
|
1,268 |
1,205 |
$992.73 |
| 82746 |
|
1,694 |
1,567 |
$953.42 |
| 86140 |
|
4,659 |
3,381 |
$936.04 |
| 88313 |
|
44 |
38 |
$917.84 |
| 83540 |
|
2,639 |
2,446 |
$905.93 |
| 81003 |
|
9,922 |
8,828 |
$865.31 |
| 85610 |
|
6,420 |
4,754 |
$855.46 |
| 84702 |
|
1,731 |
1,355 |
$808.16 |
| 85652 |
|
2,271 |
1,943 |
$721.31 |
| 82140 |
|
1,172 |
843 |
$704.98 |
| 87070 |
|
2,658 |
2,259 |
$649.44 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
215 |
196 |
$642.38 |
| 88189 |
|
16 |
12 |
$588.26 |
| 82570 |
|
2,069 |
1,859 |
$536.41 |
| 84403 |
|
415 |
397 |
$535.44 |
| 83615 |
|
3,083 |
2,124 |
$517.41 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,582 |
1,447 |
$480.00 |
| 86900 |
|
7,838 |
6,257 |
$445.93 |
| 82670 |
|
190 |
185 |
$444.83 |
| 84146 |
|
261 |
248 |
$437.38 |
| 80055 |
|
212 |
208 |
$432.80 |
| 82784 |
|
501 |
460 |
$432.35 |
| 83001 |
|
207 |
200 |
$419.08 |
| 81025 |
|
8,296 |
7,510 |
$418.43 |
| 86850 |
|
5,880 |
5,072 |
$410.35 |
| 83789 |
|
1,236 |
1,064 |
$400.60 |
| 85379 |
|
1,713 |
1,576 |
$385.83 |
| 87340 |
|
532 |
503 |
$357.54 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,798 |
4,318 |
$343.16 |
| 87205 |
|
2,297 |
1,938 |
$337.72 |
| 83002 |
|
239 |
230 |
$337.02 |
| 85730 |
|
2,700 |
2,110 |
$300.82 |
| 83498 |
|
1,315 |
1,130 |
$245.76 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,261 |
5,887 |
$232.99 |
| 84550 |
|
1,768 |
1,276 |
$216.00 |
| 86077 |
|
12 |
12 |
$208.04 |
| 86592 |
|
1,455 |
1,374 |
$207.10 |
| 87507 |
|
59 |
51 |
$199.00 |
| 83520 |
|
1,295 |
1,122 |
$186.20 |
| 84481 |
|
398 |
384 |
$185.18 |
| 82043 |
|
880 |
859 |
$182.86 |
| 86141 |
|
487 |
391 |
$166.67 |
| 82533 |
|
411 |
330 |
$163.54 |
| 80202 |
|
1,097 |
605 |
$162.07 |
| 0352U |
|
32 |
30 |
$155.20 |
| 83021 |
|
1,274 |
1,100 |
$150.41 |
| 82248 |
|
560 |
198 |
$148.77 |
| 82542 |
|
656 |
563 |
$140.63 |
| 86923 |
|
487 |
379 |
$135.28 |
| 80076 |
|
2,702 |
1,808 |
$132.77 |
| 82247 |
|
2,079 |
602 |
$130.52 |
| 82550 |
|
808 |
608 |
$130.35 |
| 82261 |
|
1,235 |
1,064 |
$116.31 |
| 82105 |
|
188 |
183 |
$113.12 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
111 |
105 |
$107.76 |
| 83550 |
|
1,363 |
1,291 |
$106.46 |
| 86704 |
|
54 |
52 |
$88.48 |
| 82760 |
|
1,235 |
1,064 |
$86.07 |
| 84478 |
|
1,740 |
367 |
$77.16 |
| 87653 |
|
156 |
142 |
$72.98 |
| 87641 |
|
601 |
558 |
$72.98 |
| 82657 |
|
39 |
37 |
$65.70 |
| 81479 |
Unlisted molecular pathology procedure |
1,239 |
1,069 |
$58.02 |
| 84153 |
|
123 |
113 |
$57.93 |
| 85014 |
|
1,329 |
660 |
$55.62 |
| 85018 |
|
1,426 |
945 |
$53.24 |
| 86038 |
|
124 |
121 |
$51.80 |
| 85007 |
|
1,067 |
507 |
$51.74 |
| 83525 |
|
195 |
190 |
$49.92 |
| 82330 |
|
340 |
149 |
$46.91 |
| 86762 |
|
56 |
52 |
$36.48 |
| 87522 |
Neg quan hep c or qual rna |
148 |
138 |
$34.43 |
| 85651 |
|
290 |
252 |
$33.41 |
| 80047 |
|
1,149 |
726 |
$31.14 |
| 82950 |
|
307 |
301 |
$28.30 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
572 |
472 |
$27.20 |
| 86880 |
|
645 |
546 |
$23.45 |
| 82565 |
|
431 |
341 |
$22.53 |
| 87210 |
|
288 |
261 |
$21.13 |
| 87015 |
|
112 |
104 |
$20.26 |
| 80177 |
|
12 |
12 |
$18.78 |
| 84155 |
|
1,138 |
238 |
$18.58 |
| 82024 |
|
15 |
15 |
$17.35 |
| 86706 |
|
56 |
55 |
$15.65 |
| 82009 |
|
127 |
113 |
$15.24 |
| 87449 |
|
156 |
146 |
$14.55 |
| 82977 |
|
266 |
117 |
$12.64 |
| 83970 |
|
109 |
107 |
$10.13 |
| 85045 |
|
687 |
501 |
$9.67 |
| 84132 |
|
172 |
101 |
$8.22 |
| 84295 |
|
154 |
71 |
$6.33 |
| 82947 |
|
144 |
89 |
$5.43 |
| 80143 |
|
1,808 |
1,613 |
$4.72 |
| 85520 |
|
177 |
69 |
$4.62 |
| 80179 |
|
1,753 |
1,579 |
$3.14 |
| 82150 |
|
29 |
26 |
$2.94 |
| 86431 |
|
43 |
39 |
$2.50 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,442 |
1,152 |
$0.00 |
| 84112 |
|
123 |
97 |
$0.00 |
| 84145 |
|
165 |
128 |
$0.00 |
| 80364 |
|
43 |
37 |
$0.00 |
| 84156 |
|
807 |
654 |
$0.00 |
| 83655 |
|
57 |
57 |
$0.00 |
| 84466 |
|
204 |
168 |
$0.00 |
| 87338 |
|
12 |
12 |
$0.00 |
| 82272 |
|
155 |
136 |
$0.00 |
| 87427 |
|
39 |
37 |
$0.00 |
| 80164 |
|
49 |
43 |
$0.00 |
| 87045 |
|
38 |
37 |
$0.00 |
| 80347 |
|
43 |
37 |
$0.00 |
| 80355 |
|
43 |
37 |
$0.00 |
| 80326 |
|
43 |
37 |
$0.00 |
| 83721 |
|
12 |
12 |
$0.00 |
| 87076 |
|
52 |
41 |
$0.00 |
| 86003 |
|
24 |
22 |
$0.00 |
| 82785 |
|
14 |
14 |
$0.00 |
| 84681 |
|
14 |
14 |
$0.00 |
| 87088 |
|
1,637 |
1,343 |
$0.00 |
| 82270 |
|
57 |
49 |
$0.00 |
| 82378 |
|
31 |
28 |
$0.00 |
| 86364 |
|
283 |
276 |
$0.00 |
| 87147 |
|
134 |
108 |
$0.00 |
| 80349 |
|
77 |
67 |
$0.00 |
| 86308 |
|
25 |
24 |
$0.00 |
| 83993 |
|
38 |
38 |
$0.00 |
| 80329 |
|
230 |
196 |
$0.00 |
| 84402 |
|
13 |
13 |
$0.00 |
| 87625 |
|
18 |
14 |
$0.00 |
| 87807 |
|
13 |
13 |
$0.00 |
| 86376 |
|
12 |
12 |
$0.00 |
| 87154 |
|
57 |
52 |
$0.00 |
| 87046 |
|
38 |
37 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$0.00 |
| 86617 |
|
12 |
12 |
$0.00 |